Hematology/Oncology Grand Rounds
Hem/Onc Grand Rounds takes place every Thursday from 7:45-8:45 a.m. in T2500
"Recent Advances & Future Directions in Hormonal Management of Metastatic Breast Cancer"
Harold Harvey, M.D.
"Review of ASH and San Antonio 2012 - #2"
Witold Rybka, M.D.
W. Christopher Ehmann, M.D.
Cristina Truica, M.D.
"Review of ASH 2012 - #1"
David Claxton, M.D.
Mark Kirschbaum, M.D.
Elliot Epner, MD, Ph.D.
"ACT 13: Patient Safety - Report Requirements"
Debra Verne, R.N., M.P.A., C.P.H.R.M.
Carol Freer, M.D.
"Complement and Thrombotic Microangiopathies"
John Chapin, M.D. - New York Presbyterian Hospital, Weill Cornell College of Medicine
"Combined Epigenetic and Immunotherapy for Hematologic Malignancies"
Elliot Epner, M.D., Ph.D.
"The Role of Diabetes and Other Factors Associated with Local and Distal Recurrence with Surgically-Resected Non-Small Cell Lung Cancer"
John Varlotto, M.D.
"Therapeutic Targets in Non-Small Cell Lung Cancer"
Yuxia Jia, M.D., Ph.D. - Columbia University Medical Center
"Serum Periostin and Survival in Metastatic Breast Cancer"
Nicholas E. Lamparella, D.O., Cancer Institute, Chief Fellow, Hematology/Oncology
"Development of Proteomic Biomarkers for Early Lung Cancer Detection and Development"
Amit Barochia, M.D., Cancer Institute, Fellow III, Hematology/Oncology
"Targeting B-Raf and K-Ras Mutation to Reverse De-Novo Resistance to EGFR TKIs in Non-Small Cell Lung Cancer"
Monika Joshi, M.D., Cancer Institute, Fellow III, Hematology/Oncology
"Intermittent VEGF Targeted Therapy in Metastatic Renal Cell Carcinoma (mRCC)"
Sarmad Sadeghi, M.D., M.S., Ph.D.